SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN HUMAN INFLAMMATORY SYNOVIAL-FLUIDS

被引:130
作者
ROUXLOMBARD, P
PUNZI, L
HASLER, F
BAS, S
TODESCO, S
GALLATI, H
GUERNE, PA
DAYER, JM
机构
[1] UNIV GENEVA, HOP CANTONAL, DIV RHEUMATOL, CH-1211 GENEVA 4, SWITZERLAND
[2] RHEUMATOL CTR, VALENS, SWITZERLAND
[3] F HOFFMANN LA ROCHE & CO LTD, PHARMACEUT RES, CH-4002 BASEL, SWITZERLAND
[4] UNIV HOSP PADUA, DIV RHEUMATOL, PADUA, ITALY
来源
ARTHRITIS AND RHEUMATISM | 1993年 / 36卷 / 04期
关键词
D O I
10.1002/art.1780360408
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To test synovial fluid (SF) for the presence of soluble fragments originating from distinct tumor necrosis factor receptors (TNF-sR55 and TNF-sR75) which bind to TNF and inhibit its biologic activity. Methods. TNF-sR55 and TNF-sR75 were measured in 62 SF samples by specific immunoassays using monoclonal antibodies. Results. Both TNF-sR were present in all of the SF tested. Their concentrations were higher in SF from patients with seropositive rheumatoid arthritis than in patients with other inflammatory arthritides. The relative amount of TNF-sR75, as compared with TNF-sR55, was higher in seropositive RA SF than in other SF. Conclusion. The balance between TNF and its specific inhibitors may be critical to the biologic outcome mediated by this cytokine.
引用
收藏
页码:485 / 489
页数:5
相关论文
共 17 条
[1]  
ADERKA D, 1991, CANCER RES, V51, P5602
[2]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[3]   CYTOKINES AND CYTOKINE INHIBITORS OR ANTAGONISTS IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1990, 33 (03) :305-315
[4]   ENHANCED EXPRESSION OF TUMOR-NECROSIS-FACTOR RECEPTOR MESSENGER-RNA AND PROTEIN IN MONONUCLEAR-CELLS ISOLATED FROM RHEUMATOID-ARTHRITIS SYNOVIAL JOINTS [J].
BRENNAN, FM ;
GIBBONS, DL ;
MITCHELL, T ;
COPE, AP ;
MAINI, RN ;
FELDMANN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (07) :1907-1912
[5]   IDENTIFICATION OF 2 TYPES OF TUMOR-NECROSIS-FACTOR RECEPTORS ON HUMAN CELL-LINES BY MONOCLONAL-ANTIBODIES [J].
BROCKHAUS, M ;
SCHOENFELD, HJ ;
SCHLAEGER, EJ ;
HUNZIKER, W ;
LESSLAUER, W ;
LOETSCHER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3127-3131
[6]   LOCALIZATION OF TUMOR-NECROSIS-FACTOR-ALPHA IN SYNOVIAL TISSUES AND AT THE CARTILAGE PANNUS JUNCTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
CHU, CQ ;
FIELD, M ;
FELDMANN, M ;
MAINI, RN .
ARTHRITIS AND RHEUMATISM, 1991, 34 (09) :1125-1132
[7]   EVIDENCE FOR DIFFERENT EFFECTS OF SOLUBLE TNF-RECEPTORS ON VARIOUS TNF MEASUREMENTS IN HUMAN BIOLOGICAL-FLUIDS [J].
ENGELBERTS, I ;
STEPHENS, S ;
FRANCOT, GJM ;
VANDERLINDEN, CJ ;
BUURMAN, WA .
LANCET, 1991, 338 (8765) :515-516
[8]  
ENGELMANN H, 1990, J BIOL CHEM, V265, P1531
[9]  
GIRARDIN E, 1992, IMMUNOLOGY, V76, P20
[10]   2 TYPES OF TNF RECEPTORS ARE EXPRESSED ON HUMAN NORMAL AND MALIGNANT B-LYMPHOCYTES [J].
HEILIG, B ;
MAPARA, M ;
BROCKHAUS, M ;
KRAUTH, K ;
DORKEN, B .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 61 (02) :260-267